Latest 10-K annual reports
YJGJ
Yijia Group CORPYijia Group Corp. announced significantly increased revenues and net income for fiscal year 2025, primarily fueled by the rapid expansion of its healthcare products segment, despite ongoing internal control deficiencies.
ZYXI
Zynex INCZynex, Inc. filed an amended annual report detailing a temporary payment suspension from Tricare, a 10% staff reduction, and identified material weaknesses in internal controls, despite achieving revenue growth and its ninth consecutive profitable year.
NASDAQ
10-K: HeartSciences Faces Going Concern Doubts Amidst Increased Losses and Nasdaq Compliance Challenges
HeartSciences Inc. reported a significant increase in net losses for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, while actively pursuing FDA clearances for its AI-ECG devices and addressing Nasdaq listing requirements.
NYSE
RPM International Inc. reported increased net sales and diluted earnings per share for fiscal year 2025, driven by strategic acquisitions and the benefits of its MAP 2025 restructuring program, despite facing challenges in certain segments and significant legal liabilities.
10-K: Sonder Holdings Grapples with Going Concern Doubt Amidst Strategic Shifts and Marriott Integration
Sonder Holdings Inc. reported a reduced net loss and improved Adjusted Free Cash Flow for fiscal year 2024, driven by portfolio optimization and a strategic integration with Marriott, yet management expressed substantial doubt about the company's ability to continue as a going concern.
10-K/A: Aquaron Acquisition Corp. Amends Annual Report, Details Nasdaq Delisting and Huture Merger Progress
Aquaron Acquisition Corp. filed an amended annual report clarifying disclosures and updating auditor opinion, while detailing its recent Nasdaq delisting and ongoing $1.0 billion merger agreement with Huture Ltd.
NASDAQ
Champions Oncology, a technology-enabled research organization, announced a significant financial turnaround in fiscal year 2025, achieving net income and positive cash flow from operations driven by increased revenue from research services and new data licensing.
OTC.Pink
Arogo Capital Acquisition Corp. reported a significant net loss, delisted from Nasdaq, terminated two prior merger agreements, and extended its business combination deadline to June 2026, while pursuing a new merger with Thailand-based telecommunications provider Tellink.
NYSE
Lamb Weston Holdings, Inc. reported a decline in net income and Adjusted EBITDA for fiscal year 2025, driven by increased costs and competitive market pressures, while announcing a new strategic plan to drive future efficiencies.
OID
MGNC
Mag Magna CORPMAG Magna Corp's latest 10-K filing reveals significant revenue growth driven by new API services, but also escalating net losses, a substantial accumulated deficit, and a recent change in control with a new CEO and loan forgiveness.
Triumph Group, Inc. filed an amendment to its Annual Report on Form 10-K to include detailed information on executive compensation, corporate governance, and security ownership for the fiscal year ended March 31, 2025.
NASDAQ
Alzamend Neuro's latest 10-K filing reveals significant financial challenges, including recurring losses and a going concern opinion, alongside a major delay in its ALZN002 Alzheimer's clinical trial, despite progress with its AL001 program.
NASDAQ
Cal-Maine Foods, the largest U.S. shell egg producer, announced a significant increase in net sales and net income for fiscal year 2025, driven by higher egg prices and strategic acquisitions, despite ongoing challenges from avian influenza and legal proceedings.
Guochun International Inc. filed its 2024 annual report, revealing no revenue, increased net losses, and substantial doubt about its ability to continue as a going concern, while actively seeking new business opportunities.
OTC.Pink
IMAA
Ima TechIMA Tech, an AI-driven digital avatar company, reported a net loss of $55,071 for fiscal year 2025 despite significant revenue growth, facing substantial doubt about its going concern status.
NYSE
AIR
Aar CORPAAR CORP. announced a substantial increase in fiscal 2025 sales and operating income, driven by robust commercial aviation demand and strategic acquisitions, despite incurring significant charges from an FCPA settlement and a business divestiture.
OTC.Pink
Old Market Capital Corporation filed an amendment to its annual report, clarifying disclosures and adding exhibits that include new rights of first refusal for its subsidiary Amplex Electric on two Ohio properties and the employment agreement for a new Assistant Controller.
NYSE
FDX
Fedex CORPFedEx Corporation reported a 6% decline in consolidated operating income for fiscal year 2025, driven by lower freight shipments, a shift to deferred services, and the expiration of its USPS contract, even as it advances major network and cost optimization initiatives including the planned spin-off of FedEx Freight.
NASDAQ
MLKN
Millerknoll, INCMillerKnoll, Inc. reported a net loss of $36.9 million for fiscal year 2025, primarily driven by significant non-cash impairment charges, despite a slight increase in net sales and growing order backlog.
IMG
Cimg INCCIMG Inc. is undergoing a significant business transformation, shifting focus to maca-infused food and beverages in Asia, but faces severe financial challenges including continued net losses and imminent Nasdaq delisting threats.
OTC.Pink
Acro Biomedical Co., Ltd. filed its annual report for 2023, revealing no revenue, substantial net losses, and significant going concern doubts.
NYSE
Darden Restaurants, Inc. announced a 6.0% increase in total sales to $12.08 billion and a 4.1% rise in diluted net earnings per share for fiscal year 2025, fueled by the acquisition of Chuys Holdings and positive same-restaurant sales.
NASDAQ
Frequency Electronics, a leader in precision time and frequency generation, announced a significant increase in revenue and net income for fiscal year 2025, primarily driven by strong performance in U.S. Government/DOD satellite programs, while also successfully remediating a material weakness in internal controls.
OTC.Pink
EVTK
Eventiko INCEventiko Inc., a development stage company, reported a net loss of $23,867 and no revenue for the fiscal year ended April 30, 2025, with auditors raising substantial doubt about its ability to continue as a going concern.
NASDAQ
AngioDynamics, a medical technology company, reported a significant reduction in net loss and an increase in gross margin for fiscal year 2025, driven by strong growth in its Med Tech segment and strategic divestitures, despite an overall revenue decline.
OQB
BTCY
Biotricity INCBiotricity Inc. filed an amended annual report for fiscal year 2025, showcasing increased revenue and improved gross profit, while still facing significant accumulated deficits and a going concern qualification from its auditors following its delisting from Nasdaq.
OTC.Pink
Deep Green Waste & Recycling, Inc. reported a significant increase in net loss and a sharp decline in revenue for the year ended December 31, 2024, leading to substantial doubt about its ability to continue as a going concern.
NYSE
NKE
Nike, INCNIKE, Inc. announced a significant downturn in its fiscal year 2025 performance, with total revenues dropping 10% and net income plummeting 44%, driven by reduced consumer traffic, increased discounts, and ongoing strategic adjustments.
NASDAQ
Kestra Medical Technologies, a commercial-stage medical device company, announced a significant 115% surge in revenue for the fiscal year ended April 30, 2025, driven by strong adoption of its ASSURE WCD, despite reporting increased net losses as it continues to invest heavily in growth and infrastructure.
10-K: Intelligent Hotel Group Shifts Strategy Amidst Significant Revenue Decline and Going Concern Doubts
Intelligent Hotel Group Ltd, formerly YCQH Agricultural Technology Co. Ltd, has ceased all prior business operations and is actively seeking new ventures in hotel, cinema, green energy, and automotive sectors, following a 52% revenue drop and a net loss in 2024, raising substantial doubt about its ability to continue as a going concern.